Remove common-pharma-interest 3-steps-to-more-sustainable-medical-labs
article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

In comparison to traditional large-scale manufacturing operations, decentralized modes of manufacturing can be more agile, more transportable, and tailored for specific modalities or production processes. These new operating models can help enable and accelerate the efforts of Pharma 4.0™

article thumbnail

Challenges for Net Zero Carbon Pharmaceutical Manufacturing

ISPE

1 Many organizations in the pharmaceutical industry have set net zero carbon goals and targets; they participate in the science-based targets initiative or sustainable markets initiative and disclose carbon emissions in databases like the Carbon Disclosure Project ( CDP ). Finalized 9 August 2021. C global warming scenario.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Research Triangle: Building a Foundation for Pharmaceutical and Biotechnology Excellence

ISPE

It’s estimated that the life sciences industry generates more than $88 billion every year for the state’s economy. By 2000, 61% of new businesses in the area were involved with drug discovery and the development of medical devices. The Garment District. 1 TEConomy Partners.

article thumbnail

Anand Patel, CMO, of Conquest Research and a Principal Investigator Shares Insights from the Significant Benefits of LX9211

PharmaShots

There is incredible work being done in the Pain space, ranging from the lab to the clinic setting, all in synchrony to address the largely unmet need of better analgesics to help patients who suffer from pain, whether acute or chronic. Smriti: Please elaborate on the details (MOA, ROA, formulation, etc.)